erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with erythromycin
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
LEVY-CAVALLERI GV and CARTILLIER H | [Pulmonary staphylococcal infection of bilateral pseudotumoral form; resistance to antibiotics; recovery after surgery]. | 1955 | Bull Soc Pathol Exot Filiales | pmid:13304609 |
RAIS H | [First attempts at treatment of trachoma with erythromycin]. | 1955 | Rev Int Trach | pmid:13311128 |
HUTCHINSON FD | Non-tuberculous spinal epidural abscess. | 1955 | Can Med Assoc J | pmid:13231018 |
SHEINAUS H and LEE CO | An evaluation of the stability of buffered erythromycin ointments. | 1955 | J Am Pharm Assoc Am Pharm Assoc (Baltim) | pmid:13233083 |
ANDERSON HH et al. | Erythromycin stearate against systemic amebiasis in Colombia. | 1955 | Am. J. Trop. Med. Hyg. | pmid:13238724 |
CLARK RK and TATERKA M | The chemistry of erythromycin. III. Acid degradation products of erythromycin B. | 1955 | Antibiot Chemother (Northfield) | pmid:24543468 |
FAIRBROTHER RW and JENNINGS RC | The dried disc technique with bacitracin, carbomycin, erythromycin, polymyxin B, and tetracycline. | 1955 | J. Clin. Pathol. | pmid:14367541 |
QUERENGESSER EI and ORMSBY HL | Ocular penetration of erythromycin. | 1955 | Can Med Assoc J | pmid:13231015 |
LAING CR and SCOTT RB | Erythromycin-polymyxin ointment in the treatment of pyoderma in children. | 1955 | Int Rec Med Gen Pract Clin | pmid:14353573 |
FORFAR JO et al. | Staphylococcal infection in the newborn treated with erythromycin. | 1955 | Lancet | pmid:14354937 |